Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05192_nanopub.RARm1w1i0_guNLw9007ORlQ8YepsLt3zOM7Mu2WNgWl5U#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05192 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05192 label "MB07811 [drugbank:DB05192]" assertion.
- drugbank:DB05192 seeAlso DB05192 assertion.
- drugbank:DB05192 description "MB07811 is the first of a novel class of product candidates discovered by Metabasis designed to lower serum cholesterol and triglycerides. MB07811, a small molecule that is administered orally, has been extensively studied preclinically and is currently undergoing clinical testing. MB07811 combines a novel thyroid hormone receptor agonist with the Company's novel HepDirect liver targeting prodrug technology. The combination of selectivity for the beta form of the receptor, liver targeting and other structural characteristics that limit extra-hepatic activity is designed to provide significant efficacy while avoiding side effects associated with activation of thyroid hormone receptors outside the liver." assertion.
- drugbank:DB05192 identifier "drugbank:DB05192" assertion.
- drugbank:DB05192 title "MB07811" assertion.
- drugbank:DB05192 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05192 drugbank_vocabulary:drugbank-id "DB05192" assertion.
- drugbank:DB05192 bio2rdf_vocabulary:x-identifiers.org DB05192 assertion.
- drugbank:DB05192 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05192" assertion.
- drugbank:DB05192 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05192 bio2rdf_vocabulary:identifier "DB05192" assertion.